Hemodynamic resuscitation in septic shock: Cardiovascular support and adjunctive therapy

Current Infectious Disease Reports

Volumn 11, Issue 5, 2009, Pages 357-364

  Fuller, Brian M ^a   Dellinger, R Phillip ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALBUMIN; CORTICOSTEROID; DOBUTAMINE; DROTRECOGIN; GLUCOSE; HEPARIN; HYPERTENSIVE FACTOR; NORADRENALIN; PLACEBO; SODIUM CHLORIDE; VASOPRESSIN;

ARTERIAL OXYGEN SATURATION; BLEEDING; BLOOD OXYGEN TENSION; BRAIN HEMORRHAGE; CENTRAL VENOUS PRESSURE; CLINICAL PRACTICE; CLINICAL TRIAL; COLLOID RESUSCITATION; COMBINATION CHEMOTHERAPY; CRYSTALLOID RESUSCITATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; GLYCEMIC CONTROL; HEART HEMODYNAMICS; HEART OUTPUT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPOGLYCEMIA; MEAN ARTERIAL PRESSURE; MONOTHERAPY; MORTALITY; PULMONARY ARTERY OCCLUSION PRESSURE; PULSE PRESSURE; RESUSCITATION; REVIEW; SEPTIC SHOCK; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; VENOUS THROMBOEMBOLISM;

EID: 69249094273     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-009-0051-1     Document Type: Review

References (57)

1. Rivers E, Nguyen B, Havstad S, et al.; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
2. Kumar AM, Roberts DM, Wood KED, et al.: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
3. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003, 31:946-955.
4. Choi PTL, Yip G, Quinonez LG, Cook DJ: Crystalloids vs. colloids in fluid resuscitation: A systematic review. Crit Care Med 1999, 27:200-210.
5. Schierhout G, Roberts I: Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomized trials. BMJ 1998, 316:961-964.
6. Finfer S, Bellomo R, Boyce N, et al.: SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
7. Dubois MJ, Orellana-Jimenez C, Melot C, et al.: Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med 2006, 34:2536-2540.
8. Dellinger RP, Levy MM, Carlet JM, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
9. Calvin JE, Driedger AA, Sibbald WJ: The hemodynamic effect of rapid fluid infusion in critically ill patients. Surgery 1981, 90:61-76.
10. Reuse C, Vincent JL, Pinsky MR: Measurements of right ventricular volumes during fluid challenge. Chest 1990, 98:1450-1454.
11. Schneider AJ, Teule GJJ, Groeneveld ABJ, et al.: Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: A combined hemodynamic and radionuclide study. Am Heart J 1988, 116:103-112.
12. Diebel LN, WilsoA RF, Tagett MG, et al.: End-diastolic volume: a better indicator of preload in the critically ill. Arch Surg 1992, 127:817-822.
13. Diebel L, Wilson RF, Heins J, et al.: End-diastolic volume vs pulmonary artery wedge pressure in evaluating cardiac preload in trauma patients. J Trauma 1994, 37:950-955.
14. Tavernier B, Makhotine O, Lebuffe G, et al.: Systolic pressure variation as a guide to fluid therapy in patients with sepsis-induced hypotension. Anesthesiology 1998, 89:1313-1321.
15. Wagner JG, Leatherman JW: Right ventricular end-diastolic volume as a predictor of the hemodynamic response to a fluid challenge. Chest 1998, 113:1048-1054.
16. Kumar A, Anel R, Bunnell E, et al.: Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volumes, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 2004, 32:691-699.
17. Osman D, Ridel C, Ray P, et al.: Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 2007, 35:64-68.
18. Magder S, Georgiadis G, Cheong T, et al.: Respiratory variations in right atrial pressure predict the response to fluid challenge. J Crit Care 1992, 7:76-85.
19. Michard F, Boussat S, Chemla D, et al.: Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000, 162:134-138.
20. Tavernier B, Makhotine O, Lebuffe G, et al.: Systolic pressure variation as a guide to fluid therapy in patients with sepsis induced hypotension. Anesthesiology 1998, 89:1313-1321.
21. Preisman S, Kogan S, Berkenstadt H, et al.: Predicting fluid responsiveness in patients undergoing cardiac surgery: Functional haemodynamic parameters including the respiratory systolic variation test and static preload indicators. Br J Anaesth 2005, 95:746-755.
22. Solus-Biguenet H, Fleyfel M, Tavernier B, et al.: Noninvasive prediction of fluid responsiveness during major hepatic surgery. Br J Anaesth 2006, 97:808-816.
23. Monnet X, Rienzo M, Osman D, et al.: Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 2006, 34:1402-1407.
24. Maizel J, Airapetian N, Lorne E, et al.: Diagnosis of central hypovolemia by using passive leg raising. Intensive Care Med 2007, 33:1133-1138.
25. Lafanechere A, Pene F, Goulenok C, et al.: Changes in aortic blood flow induced by passive leg raising predict fluid responsiveness in critically ill patients. Crit Care 2006, 10:R132.
26. Nguyen HB, Rivers EP, Knoblich BP: Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004, 32:1637-1642.
27. Hollenberg SM: Vasopressor support in septic shock. Chest 2007, 132:1678-1687.
28. Bersten AD, Holt AW: Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995, 3:650-661.
29. Kirchheim HR, Ehmke H, Hackenthal E, et al.: Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 1987, 410:441-449.
30. LeDoux D, Astiz ME, Carpati CM, Rackow EC: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000 28:2729-2732.
31. Bourgoin A, Leone M, Delmas A, et al.: Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function. Crit Care Med 2005, 33:780-786.
32. Varpula M, Tallgren M, Saukkonen K, et al.: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31:1066-1071.
33. Annane D, Vigno P, Renault A, et al.: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomized trial. Lancet 2007, 370:676-684.
34. Russell JA, Walley KR, Singer J, et al.: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887.
35. Parrillo JE: Septic shock-vasopressin, norepinephrine, and urgency. N Engl J Med 2008, 358:954-956.
36. Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
37. Briegel J, Forst H, Haller M, et al.: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999 27:723-732.
38. Bollaert PE, Charpentier C, Levy B, et al.: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645-650.
39. Dellinger RP, Carlet JM, Masur H, et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873.
40. Sprung CL, Annane D, Keh D, et al.: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
41. Marik PE, Pastores SM, Annane D, et al.: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36:1937-1949.
42. Cinel I, Dellinger RP: Advance in pathogenesis and management of sepsis. Curr Opin Inect Dis 2007, 20:345-352.
43. Bernard GR, Vincent JL, Laterre PF, et al.: Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
44. Ely EW, Laterre PF, Angus DC, et al.: Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003, 31:12-19.
45. Abraham E, Laterre PF, Garg R, et al.: Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005, 353:1332-1341.
46. Wheeler A, Steingrub J, Schmidt GA, et al.: A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial. Crit Care Med 2008, 36:14-23.
47. Kanji, S, Perreault MM, Chant C, et al.: Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: A Canadian multicenter observational study. Intensive Care Med 2007, 33: 517-23.
48. De Backer D, Verdant C, Chierego M, et al.: Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006, 34:1918-1924.
49. Trzeciak S, Cinel I, Dellinger RP, et al.: Resuscitating the microcirculation in sepsis: The central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008, 15:399-413.
50. Chapital A, Yu M, Ho H, et al.: Using transcutaneous oxygen pressure measurements as selection criteria for activated protein C use. J Trauma 2008, 65:30-33.
51. Levi M, Levy M, Williams MD, et al.: Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med 2007, 176:483-490.
52. van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
53. van den Berghe G, Wilmer A, Hermans G, et al.: Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461.
54. Brunkhorst FM, Engel C, Bloos F, et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
55. Treggiari MM, Karir V, Yanez ND, et al.: Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008, 12:R29.
56. Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008, 300:933-944.
57. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, et al.: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.